Friend erythroleukemia revisited

Blood

Volumn 96, Issue 12, 2000, Pages 3675-3680

  Ney, P A ^a   D'Andrea, A D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; GENE PRODUCT; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

CANCER RESISTANCE; CELL PROLIFERATION; CELL SURFACE; ERYTHROBLAST; ERYTHROLEUKEMIA; ERYTHROPOIESIS; FRIEND LEUKEMIA; FRIEND LEUKEMIA VIRUS; GENETIC SUSCEPTIBILITY; HEMATOPOIETIC CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034554856     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3675.h8003675_3675_3680     Document Type: Review

References (101)

1. Cell-free transmission in adult swiss mice of a disease having the character of a leukemia
2. Fv2 is a truncated form of the Stk/RON receptor tyrosine kinase
3. Friend virus-induced erythroleukemia and the multistage nature of cancer
4. The interaction of the erythropoietin receptor and gp55. Oncogenes in the development of leukaemia
5. Emergence of tumorigenic cells during the course of Friend virus leukemias
6. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor
7. Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with Friend virus
8. Kinetics of erythroid precursors in mice infected with the anemic or the polycythemic strain of Friend leukemia virus
9. Friend leukaemia virus-transformed cells, unlike normal stem cells, form spleen colonies in SI/Sid mice
10. Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus
11. Modification of the Friend virus disease by splenectomy
12. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
13. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus
14. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: Relationship of inactivation to dominant transforming alleles
15. Spi-1 is a putative oncogene in virally induced murine erythroleukemias
16. A common site for immortalizing proviral integrations in Friend erythroleukemia: Molecular cloning and characterization
17. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells
18. Molecular biology of Friend viral erythroleukemia
19. Erythroleukaemia induction by the Friend spleen focus-forming virus
20. Erythrocyte production in mice infected by the polycythaemia-inducing Friend virus or by the anaemia-inducing Friend virus
21. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene
22. The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid
23. Polycythemia and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro
24. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells
25. Splenic erythroblasts in anemia-inducing Friend disease: A source of cells for studies of erythropoietin-mediated differentiation
26. The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia
27. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line
28. Expression cloning of the murine erythropoietin receptor
29. Erythropoietin receptor and interleukin receptor beta chain: A new receptor family
30. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain
31. Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells
32. The Friend spleen focus-forming virus glycoprotein interacts with the erythropoietin receptor in an intracellular compartment and affects receptor metabolism
33. Human erythropoietin receptor: Cloning expression and biologic characterization
34. Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line
35. Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth
36. Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain
37. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein
38. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus
39. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55
40. Role of the transmembrane sequence of spleen focus-forming virus gp55 in erythroleukemogenesis
41. Cell surface organization of the erythropoietin receptor complex differs depending on its mode of activation
42. Polycythaemia- and anaemia-inducing strains of spleen focus-forming virus differ in post-translational processing of envelope-related glycoproteins
43. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity
44. Rearrangement and expression of erythropoietin genes in transformed mouse cells
45. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene
46. Unregulated expression of the erythropoietin receptor caused by insertion of spleen focus-forming virus long terminal repeat in a murine erythroleukemia cell line
47. Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3Cl-2 Friend leukemia cell line
48. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth regulatory domains
49. A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line
50. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
51. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
52. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
53. Hematopoietic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev)
54. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: Implications for soluble receptor function
55. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
56. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
57. NMR structure of human erythropoietin and a comparison with its receptor bound conformation
58. Efficiency of signalling through cytokine receptors depends critically on receptor orientation
59. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 A
60. Mimicry of erythropoietin by a nonpeptide molecule
61. Evidence for an accessory component that increases the affinity of the erythropoietin receptor
62. Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells
63. A second erythropoietin receptor subunit
64. Structure of the murine erythropoietin receptor complex. Characterization of the erythropoietin cross-linked proteins
65. 125I-EPO cross-linking in cells expressing wild-type or mutant receptors
66. In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130
67. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
68. Erythropoietin and interleukin-2 activate distinct JAK kinase family members
69. Distinct downstream signaling mechanism between erythropoietin receptor and interleukin-2 receptor
70. Genetic evidence for an additional factor required for erythropoietin-induced signal transduction
71. Interaction of the erythropoietin and stem-cell-factor receptors
72. Genetic and cellular basis of susceptibility or resistance to Friend leukemia virus infection in mice
73. Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance
74. Positional cloning of the mouse retrovirus restriction gene Fv1
75. Mechanism of genetic resistance to Friend virus leukemia in mice. V. Relevance of Fv-3 gene in the regulation of in vivo immunosuppression
76. Immunity to retroviral infection: The Friend virus model
77. A host gene controlling early anaemia or polycythaemia induced by Friend erythroleukaemia virus
78. Genetic control by the W locus of susceptibility to (Friend) spleen focus-forming virus
79. Mutant SI alleles of mice affect susceptibility to Friend spleen focus-forming virus
80. Fv-2: Identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice
81. The Fv-2 gene controls induction of erythroid burst formation by Friend virus infection in vitro: Studies of growth regulators and viral replication
82. Cellular site and mode of Fv-2 gene action
83. Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions of erythroleukemia
84. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells
85. Erb-B: Growth factor receptor turned oncogene
86. The v-sea oncogene of avian erythroblastosis retrovirus S13: Another member of the protein-tyrosine kinase gene family
87. Physical and functional interactions between the erythropoietin receptor and a truncated form of the STK/RON receptor tyrosine kinase
88. RON is a hetrodimeric tyrosine receptor kinase activated by the HGF homologue MSP
89. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase
90. The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse
91. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
92. The HGF receptor family: Unconventional signal transducers for invasive cell growth
93. Induction of cell shape changes through activation of the IL-3 common β-chain receptor by the RON receptor-type tyrosine kinase
94. HGF activates signal transduction from EPO receptor on human cord blood CD34+/CD45+ cells
95. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines
96. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family
97. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV
98. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus
99. Friend murine leukaemia virus is integrated at a common site in most primary spleen turnouts of erythroleukaemic animals
100. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity
101. Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: Evidence that NF-E2 is essential for globin expression